Stryker Corporation

Company: Stryker Corporation
Ticker: SYK

Submit Your Information

If you suffered a loss on your Stryker Corporation investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filling out this form mean you have joined any lawsuit.

First Name*

Last Name*

Email*

Phone*

City

State

Country

Total # of shares

First Purchase Date

Last Purchase Date

Estimated Loss Range

Check here if you still hold any shares.

Check here if you are a current or former employee of the company.

Check here if you purchased any shares before

Additional Comments

Background

On July 30, 2026, Stryker reported second quarter 2026 results. Among other things, the Company reported a “supply disruption resulted in a meaningful backorder situation with lost sales in the quarter. We have addressed the issue, and back orders should reach a manageable level by the end of Q3."

On this news, shares of Stryker fell $22.34 or 6.43% to close at $325.70 per share on July 31, 2026, thereby injuring investors.

On September 8, 2026, the Company participated in the Wells Fargo Healthcare Conference, during which the Company’s CFO Preston Wells told investors the Company had “anticipated that” the manufacturing issue “would rectify itself in the third quarter.” But “[w]hat we're seeing is that is continuing into the third quarter and certainly, it will continue.”

On this news, shares of Stryker fell $26.70, or 8.8%, to close at $276.43 per share on September 8, 2026, thereby injuring investors further.

Submit Your Information